GHSI (guardionhealth.com) יחס שווי שוק לשווי בספרים

Guardion Health Science relies on patient trust in its evidence-based vision nutraceuticals. Brand distribution synergy is driven by partnerships with clinics to promote Lumega-Z, while the environmental footprint is minimized through outsourced manufacturing. The company's relative capitalization metric confirms the market consensus, with the latest value recorded as 0.30.

To filter risks for Guardion Health Science (GHSI), it is necessary to assess the degree of asset overvaluation. This indicator is calculated as the ratio of market value to net assets, measuring the gap between exchange quotes and book value. Analyzing the change in the market-to-book value ratio reveals speculative deviations from the fundamental base. For Guardion Health Science, such a premium reflects market confidence in the capital of ophthalmologist-scientists and the value of their evidence-based research.